Jensen MK - Search Results

1

A phase II study of vorinostat (MK-0683) in patients with polycythaemia vera and essential thrombocythaemia.

Andersen CL, McMullin MF, Ejerblad E, Zweegman S, Harrison C, Fernandes S, Bareford D, Knapper S, Samuelsson J, Löfvenberg E, Linder O, Andreasson B, Ahlstrand E, Jensen MK, Bjerrum OW, Vestergaard H, Larsen H, Klausen TW, Mourits-Andersen T, Hasselbalch HC. Andersen CL, et al. Among authors: jensen mk. Br J Haematol. 2013 Aug;162(4):498-508. doi: 10.1111/bjh.12416. Epub 2013 Jun 11. Br J Haematol. 2013. PMID: 23758082 Clinical Trial.

2

Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat.

Andersen CL, Bjørn ME, McMullin MF, Harrison C, Samuelsson J, Ejerblad E, Zweegman S, Fernandes S, Bareford D, Knapper S, Löfvenberg E, Linder O, Andreasson B, Ahlstrand E, Jensen MK, Bjerrum OW, Vestergaard H, Larsen H, Klausen TW, Mourits-Andersen T, Skov V, Thomassen M, Kruse T, Grønbæk K, Hasselbalch HC. Andersen CL, et al. Among authors: jensen mk. Leuk Res. 2014 Jul;38(7):816-21. doi: 10.1016/j.leukres.2014.04.002. Epub 2014 Apr 14. Leuk Res. 2014. PMID: 24836761 Clinical Trial.

3

Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α.

Riley CH, Hansen M, Brimnes MK, Hasselbalch HC, Bjerrum OW, Straten PT, Svane IM, Jensen MK. Riley CH, et al. Among authors: jensen mk. Eur J Haematol. 2015 Mar;94(3):227-34. doi: 10.1111/ejh.12420. Epub 2014 Sep 24. Eur J Haematol. 2015. PMID: 25082025

4

Incidence, clinical features and outcome of essential thrombocythaemia in a well defined geographical area.

Jensen MK, de Nully Brown P, Nielsen OJ, Hasselbalch HC. Jensen MK, et al. Eur J Haematol. 2000 Aug;65(2):132-9. doi: 10.1034/j.1600-0609.2000.90236.x. Eur J Haematol. 2000. PMID: 10966175

5

Whole-blood transcriptional profiling of interferon-inducible genes identifies highly upregulated IFI27 in primary myelofibrosis.

Skov V, Larsen TS, Thomassen M, Riley CH, Jensen MK, Bjerrum OW, Kruse TA, Hasselbalch HC. Skov V, et al. Among authors: jensen mk. Eur J Haematol. 2011 Jul;87(1):54-60. doi: 10.1111/j.1600-0609.2011.01618.x. Eur J Haematol. 2011. PMID: 21447007

6

Elevated soluble urokinase plasminogen activator receptor in plasma from patients with idiopathic myelofibrosis or polycythaemia vera.

Jensen MK, Riisbro R, de Nully Brown P, Brünner N, Hasselbalch HC. Jensen MK, et al. Eur J Haematol. 2002 Jul;69(1):43-9. doi: 10.1034/j.1600-0609.2002.01732.x. Eur J Haematol. 2002. PMID: 12270061

7

Interferon-alpha in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms. Status and perspectives.

Hasselbalch HC, Larsen TS, Riley CH, Jensen MK, Kiladjian JJ. Hasselbalch HC, et al. Among authors: jensen mk. Curr Drug Targets. 2011 Mar 1;12(3):392-419. doi: 10.2174/138945011794815275. Curr Drug Targets. 2011. PMID: 21143149 Review.

8

Circulating YKL-40 in myelofibrosis a potential novel biomarker of disease activity and the inflammatory state.

Bjørn ME, Andersen CL, Jensen MK, Hasselbalch HC. Bjørn ME, et al. Among authors: jensen mk. Eur J Haematol. 2014 Sep;93(3):224-8. doi: 10.1111/ejh.12332. Epub 2014 Apr 25. Eur J Haematol. 2014. PMID: 24689875

9

Interferon-α induces marked alterations in circulating regulatory T cells, NK cell subsets, and dendritic cells in patients with JAK2V617F-positive essential thrombocythemia and polycythemia vera.

Riley CH, Brimnes MK, Hansen M, Jensen MK, Hasselbalch HC, Kjaer L, Straten PT, Svane IM. Riley CH, et al. Among authors: jensen mk. Eur J Haematol. 2016 Jul;97(1):83-92. doi: 10.1111/ejh.12687. Epub 2015 Nov 26. Eur J Haematol. 2016. PMID: 26385526

10

Increased gene expression of histone deacetylases in patients with Philadelphia-negative chronic myeloproliferative neoplasms.

Skov V, Larsen TS, Thomassen M, Riley CH, Jensen MK, Bjerrum OW, Kruse TA, Hasselbalch HC. Skov V, et al. Among authors: jensen mk. Leuk Lymphoma. 2012 Jan;53(1):123-9. doi: 10.3109/10428194.2011.597905. Epub 2011 Aug 1. Leuk Lymphoma. 2012. PMID: 21806350

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

562 results

Search Page

Filters